Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion. | Front Oncol | 2022 | 35978827 | PubTator, text mining | PubMed |
| NORAD Promotes the Viability, Migration, and Phenotypic Switch of Human Vascular Smooth Muscle Cells during Aortic Dissection via LIN28B-Mediated TGF-β Promotion and Subsequent Enhanced Glycolysis. | Biomed Res Int | 2022 | 35971448 | PubTator, text mining | PubMed |
| lncRNA CYTOR promotes aberrant glycolysis and mitochondrial respiration via HNRNPC-mediated ZEB1 stabilization in oral squamous cell carcinoma. | Cell Death Dis | 2022 | 35963855 | PubTator, text mining | PubMed |
| The Analysis of SNPs' Function in miR-21 and miR146a/b in Multiple Sclerosis and Active Lesions: An In Silico Study. | Bioinform Biol Insights | 2022 | 35958297 | PubTator, text mining | PubMed |
| Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA. | Int J Mol Sci | 2022 | 35955552 | PubTator, text mining | PubMed |
| Pathogenic Roles of RNA-Binding Proteins in Sarcomas. | Cancers (Basel) | 2022 | 35954475 | PubTator, text mining | PubMed |
| Stem Cells as Target for Prostate cancer Therapy: Opportunities and Challenges. | Stem Cell Rev Rep | 2022 | 35951166 | PubTator, text mining | PubMed |
| Circ_0061140 Facilitates Adenomyosis Progression by Upregulating LIN28B in vitro. | Gynecol Obstet Invest | 2022 | 35947965 | PubTator, text mining | PubMed |
| STAT3-mediated upregulation of LINC00520 contributed to temozolomide chemoresistance in glioblastoma by interacting with RNA-binding protein LIN28B. | Cancer Cell Int | 2022 | 35945579 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Prognostic Value and Immune Landscapes of m5C-Related lncRNAs in Lung Squamous Cell Carcinoma. | Front Genet | 2022 | 35938020 | PubTator, text mining | PubMed |
| The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. | Front Oncol | 2022 | 35936737 | PubTator, text mining | PubMed |
| Prognostic Roles of ceRNA Network-Based Signatures in Gastrointestinal Cancers. | Front Oncol | 2022 | 35924172 | PubTator, text mining | PubMed |
| Immunization of preterm infants: current evidence and future strategies to individualized approaches. | Semin Immunopathol | 2022 | 35922638 | PubTator, text mining | PubMed |
| The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations. | Int J Biol Macromol | 2022 | 35907451 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions. | Front Oncol | 2022 | 35898889 | PubTator, text mining | PubMed |
| NF-κB: A Druggable Target in Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35884618 | PubTator, text mining | PubMed |
| UFMylation System: An Emerging Player in Tumorigenesis. | Cancers (Basel) | 2022 | 35884562 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. | Cell Death Discov | 2022 | 35879279 | PubTator, text mining | PubMed |
| UPF1/circRPPH1/ATF3 feedback loop promotes the malignant phenotype and stemness of GSCs. | Cell Death Dis | 2022 | 35871061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=24